BioCentury
ARTICLE | Company News

Xenerex secures patent for MAb process

February 12, 2001 8:00 AM UTC

Xenerex, a subsidiary of Avanir (AVN), acquired Idec's ownership interest in U.S. Patent No. 5,958,765 covering a process for generating human monoclonal antibodies using human spleen cells grafted in...